Inventor
TARGAN STEPHAN R
US48 patents
⚠️ This page may combine multiple inventors who share the name “TARGAN STEPHAN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEDARS SINAI MEDICAL CENTER
33 patentsUS5968741AOct 19, 1999
Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
CEDARS SINAI MEDICAL CENTER86 citations95
US5916748AJun 29, 1999
Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
CEDARS SINAI MEDICAL CENTER56 citations95
US5830675ANov 3, 1998
Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
CEDARS SINAI MEDICAL CENTER58 citations94
US5750355AMay 12, 1998
Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis
CEDARS SINAI MEDICAL CENTER68 citations94
US11236393B2Feb 1, 2022
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease
CEDARS SINAI MEDICAL CENTER25 citations92
US11268149B2Mar 8, 2022
Diagnosis and treatment of inflammatory bowel disease
CEDARS SINAI MEDICAL CENTER28 citations91
US10316083B2Jun 11, 2019
Signature of TL1A (TNFSF15) signaling pathway
CEDARS SINAI MEDICAL CENTER15 citations91
US5874233AFeb 23, 1999
Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
CEDARS SINAI MEDICAL CENTER48 citations91
US5681699AOct 28, 1997
Methods of diagnosing ulcerative colitis and Crohn's disease
CEDARS SINAI MEDICAL CENTER36 citations91
US5932429AAug 3, 1999
Methods of diagnosing clinical subtypes of crohn's disease
CEDARS SINAI MEDICAL CENTER48 citations90
US5937862AAug 17, 1999
Methods of determining the risk of pouchitis development
CEDARS SINAI MEDICAL CENTER37 citations88
US10633449B2Apr 28, 2020
Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
CEDARS SINAI MEDICAL CENTER12 citations84
US11434296B2Sep 6, 2022
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
CEDARS SINAI MEDICAL CENTER5 citations83
US9332741B2May 10, 2016
TL1A model of inflammation fibrosis and autoimmunity
CEDARS SINAI MEDICAL CENTER9 citations82
US11312768B2Apr 26, 2022
Signature of TL1A (TNFSF15) signaling pathway
CEDARS SINAI MEDICAL CENTER5 citations81
US7662569B2Feb 16, 2010
Methods of assessing Crohn's disease patient phenotype by I2 serologic response
CEDARS SINAI MEDICAL CENTER13 citations81
US11186872B2Nov 30, 2021
Methods of diagnosing inflammatory bowel disease through RNASET2
CEDARS SINAI MEDICAL CENTER8 citations77
US7993866B2Aug 9, 2011
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72
US7993867B2Aug 9, 2011
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72
US7993865B2Aug 9, 2011
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72
US6534263B1Mar 18, 2003
Methods of screening for Crohn's disease using TNF microsatellite alleles
CEDARS SINAI MEDICAL CENTER6 citations72
US6008335ADec 28, 1999
Methods of screening for ulcerative colitis and Crohn's disease
CEDARS SINAI MEDICAL CENTER14 citations72
US6001569ADec 14, 1999
Methods of screening for Crohn's disease using TNF microsatellite alleles
CEDARS SINAI MEDICAL CENTER9 citations72
US10544459B2Jan 28, 2020
Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
CEDARS SINAI MEDICAL CENTER4 citations70
US12590160B2Mar 31, 2026
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
CEDARS SINAI MEDICAL CENTER0 citations61
US6884590B1Apr 26, 2005
Methods of screening for ulcerative colitis and crohn's disease
CEDARS SINAI MEDICAL CENTER2 citations61
US12084722B2Sep 10, 2024
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease
CEDARS SINAI MEDICAL CENTER0 citations60
US12018086B2Jun 25, 2024
Kit comprising contiguous nucleobases, including position 76, of RS5745994
CEDARS SINAI MEDICAL CENTER0 citations60
US11473061B2Oct 18, 2022
Systems and methods for growth of intestinal cells in microfluidic devices
CEDARS SINAI MEDICAL CENTER0 citations60
US12269873B2Apr 8, 2025
Signature of TL1A (TNFSF15) signaling pathway
CEDARS SINAI MEDICAL CENTER0 citations59
US12110555B2Oct 8, 2024
Diagnosis and treatment of inflammatory bowel disease
CEDARS SINAI MEDICAL CENTER0 citations59
US7790370B2Sep 7, 2010
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
CEDARS SINAI MEDICAL CENTER5 citations59
US12540358B2Feb 3, 2026
RNASET2 compositions and methods of treatment therewith
CEDARS SINAI MEDICAL CENTER0 citations57
UNIV CALIFORNIA
3 patentsUS5691151ANov 25, 1997
Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
UNIV CALIFORNIA76 citations96
US7138237B1Nov 21, 2006
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
UNIV CALIFORNIA35 citations95
US6074835AJun 13, 2000
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
UNIV CALIFORNIA75 citations90
PROMETHEUS BIOSCIENCES INC
3 patentsUS11440954B2Sep 13, 2022
Optimized anti-TL1A antibodies
PROMETHEUS BIOSCIENCES INC7 citations82
US11292848B2Apr 5, 2022
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
PROMETHEUS BIOSCIENCES INC14 citations82
US11999789B2Jun 4, 2024
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
PROMETHEUS BIOSCIENCES INC2 citations69